276 related articles for article (PubMed ID: 37371986)
21.
Bautista-Aguilera ÓM; Alonso JM; Catto M; Iriepa I; Knez D; Gobec S; Marco-Contelles J
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364263
[TBL] [Abstract][Full Text] [Related]
22. A review on ferulic acid and analogs based scaffolds for the management of Alzheimer's disease.
Singh YP; Rai H; Singh G; Singh GK; Mishra S; Kumar S; Srikrishna S; Modi G
Eur J Med Chem; 2021 Apr; 215():113278. PubMed ID: 33662757
[TBL] [Abstract][Full Text] [Related]
23. Multifunctional 5,6-dimethoxybenzo[d]isothiazol-3(2H)-one-N-alkylbenzylamine derivatives with acetylcholinesterase, monoamine oxidases and β-amyloid aggregation inhibitory activities as potential agents against Alzheimer's disease.
Xu R; Xiao G; Li Y; Liu H; Song Q; Zhang X; Yang Z; Zheng Y; Tan Z; Deng Y
Bioorg Med Chem; 2018 May; 26(8):1885-1895. PubMed ID: 29500132
[TBL] [Abstract][Full Text] [Related]
24. Astrocyte-Targeted Transporter-Utilizing Derivatives of Ferulic Acid Can Have Multifunctional Effects Ameliorating Inflammation and Oxidative Stress in the Brain.
Montaser A; Huttunen J; Ibrahim SA; Huttunen KM
Oxid Med Cell Longev; 2019; 2019():3528148. PubMed ID: 31814871
[TBL] [Abstract][Full Text] [Related]
25. Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease.
Bai P; Wang K; Zhang P; Shi J; Cheng X; Zhang Q; Zheng C; Cheng Y; Yang J; Lu X; Sang Z
Eur J Med Chem; 2019 Dec; 183():111737. PubMed ID: 31581002
[TBL] [Abstract][Full Text] [Related]
26. Pyridoxine-resveratrol hybrids Mannich base derivatives as novel dual inhibitors of AChE and MAO-B with antioxidant and metal-chelating properties for the treatment of Alzheimer's disease.
Yang X; Qiang X; Li Y; Luo L; Xu R; Zheng Y; Cao Z; Tan Z; Deng Y
Bioorg Chem; 2017 Apr; 71():305-314. PubMed ID: 28267984
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and evaluation of chalcone Mannich base derivatives as multifunctional agents for the potential treatment of Alzheimer's disease.
Zhang X; Song Q; Cao Z; Li Y; Tian C; Yang Z; Zhang H; Deng Y
Bioorg Chem; 2019 Jun; 87():395-408. PubMed ID: 30921741
[TBL] [Abstract][Full Text] [Related]
28. 2-Hydroxy-4-benzyloxylimine Resveratrol Derivatives as Potential Multifunctional Agents for the Treatment of Parkinson's Disease.
Cao Z; Zhang T; Fu X; Wang X; Xia Q; Zhong L; Zhu J
ChemMedChem; 2023 Mar; 18(6):e202200629. PubMed ID: 36622947
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of 4-hydroxy-methylpiperidinyl-N-benzyl-acylarylhydrazone hybrids designed as novel multifunctional drug candidates for Alzheimer's disease.
Macedo Vaz S; de Freitas Silva M; Dos Reis Rosa Franco G; Jorge R Guimarães M; Motta R da Silva F; Gonçalves Castro N; Alvim Guedes I; Dardenne LE; Amaral Alves M; Garrett da Costa R; Beserra Pinheiro G; Germino Veras L; Renata Mortari M; Pruccoli L; Tarozzi A; Viegas C
Bioorg Med Chem; 2022 Oct; 71():116952. PubMed ID: 35930852
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory potential of plant secondary metabolites on anti-Parkinsonian drug targets: Relevance to pathophysiology, and motor and non-motor behavioural abnormalities.
Mazumder MK; Borah A; Choudhury S
Med Hypotheses; 2020 Apr; 137():109544. PubMed ID: 31954292
[TBL] [Abstract][Full Text] [Related]
31. From anti-Parkinson's drug rasagiline to novel multitarget iron chelators with acetylcholinesterase and monoamine oxidase inhibitory and neuroprotective properties for Alzheimer's disease.
Zheng H; Amit T; Bar-Am O; Fridkin M; Youdim MB; Mandel SA
J Alzheimers Dis; 2012; 30(1):1-16. PubMed ID: 22387411
[TBL] [Abstract][Full Text] [Related]
32. Boron Nitride Nanoparticles Loaded with a Boron-Based Hybrid as a Promising Drug Carrier System for Alzheimer's Disease Treatment.
Yıldırım ÖÇ; Arslan ME; Öner S; Cacciatore I; Di Stefano A; Mardinoglu A; Turkez H
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897815
[TBL] [Abstract][Full Text] [Related]
33. Fluorinated-antioxidant derivatives with improved pharmacological activity: a theoretical study.
Zhang Y; Dou D; Gu W
J Biomol Struct Dyn; 2021 Jul; 39(11):3874-3881. PubMed ID: 32448051
[TBL] [Abstract][Full Text] [Related]
34. Multitarget drug design strategy against Alzheimer's disease: Homoisoflavonoid Mannich base derivatives serve as acetylcholinesterase and monoamine oxidase B dual inhibitors with multifunctional properties.
Li Y; Qiang X; Luo L; Yang X; Xiao G; Zheng Y; Cao Z; Sang Z; Su F; Deng Y
Bioorg Med Chem; 2017 Jan; 25(2):714-726. PubMed ID: 27923535
[TBL] [Abstract][Full Text] [Related]
35. Discovery of novel 2-hydroxyl-4-benzyloxybenzyl aniline derivatives as potential multifunctional agents for the treatment of Parkinson's disease.
Cao Z; Fu X; Wang X; Zhang T; Zhong L; Xia Q; Zhu J
Eur J Med Chem; 2023 Mar; 249():115142. PubMed ID: 36716641
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic potential of ferulic acid and its derivatives in Alzheimer's disease-A systematic review.
Phadke AV; Tayade AA; Khambete MP
Chem Biol Drug Des; 2021 Nov; 98(5):713-721. PubMed ID: 34240555
[TBL] [Abstract][Full Text] [Related]
37. Modification of the association between early adversity and obsessive-compulsive disorder by polymorphisms in the MAOA, MAOB and COMT genes.
McGregor NW; Hemmings SMJ; Erdman L; Calmarza-Font I; Stein DJ; Lochner C
Psychiatry Res; 2016 Dec; 246():527-532. PubMed ID: 27821364
[TBL] [Abstract][Full Text] [Related]
38. New Flavone-Cyanoacetamide Hybrids with a Combination of Cholinergic, Antioxidant, Modulation of β-Amyloid Aggregation, and Neuroprotection Properties as Innovative Multifunctional Therapeutic Candidates for Alzheimer's Disease and Unraveling Their Mechanism of Action with Acetylcholinesterase.
Basha SJ; Mohan P; Yeggoni DP; Babu ZR; Kumar PB; Rao AD; Subramanyam R; Damu AG
Mol Pharm; 2018 Jun; 15(6):2206-2223. PubMed ID: 29745222
[TBL] [Abstract][Full Text] [Related]
39. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors:
Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Astakhova TY; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Korabecny J; Soukup O; Bachurin SO; Richardson RJ
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164325
[TBL] [Abstract][Full Text] [Related]
40. Novel 3-benzylidene/benzylphthalide Mannich base derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
Cao Z; Song Q; Yu G; Liu Z; Cong S; Tan Z; Deng Y
Bioorg Med Chem; 2021 Apr; 35():116074. PubMed ID: 33640707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
